|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.225 SEK | +0.10% |
|
+0.97% | +13.04% |
| 07-25 | Active Biotech Doses First Patient in Amended Ho172 Clinical Study of Tasquinimod in Myelofibrosis | CI |
| 07-24 | Active Biotech Doses First Patient in Amended Tasquinimod Myelofibrosis Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.99% | +5.68% | +1.40% | +17.60% | +11.10% | +55.61% | +69.77% | +217.16% | +6,073.64% | 57.28B | |
| -1.92% | +6.03% | +5.77% | +24.90% | +37.91% | +40.64% | +80.66% | -15.96% | - | 54.99B | |
| -0.46% | -1.29% | +3.42% | -20.90% | -38.57% | +2.86% | +425.15% | +347.36% | +878.23% | 23.18B | |
| -2.97% | -2.35% | -2.07% | -15.29% | -6.17% | -22.53% | -15.34% | -68.79% | - | 22.59B | |
| -1.13% | +1.05% | +9.58% | +16.17% | +22.96% | +20.81% | -7.73% | -64.17% | - | 20.46B | |
| +0.11% | +2.03% | +9.66% | +10.40% | -7.03% | +25.84% | -29.94% | -31.60% | +57.96% | 17.56B | |
| -0.10% | +1.88% | +17.88% | +10.05% | +30.93% | +34.42% | +545.91% | - | - | 15.67B | |
| -1.30% | -5.02% | +9.01% | +103.07% | +167.88% | +170.77% | +310.94% | +1,485.91% | +635.36% | 14.46B | |
| -0.50% | -0.98% | +1.10% | +23.21% | +26.33% | +21.43% | +179.36% | +235.37% | +540.86% | 13.92B | |
| +0.21% | -1.62% | +6.21% | +6.27% | -6.50% | +82.48% | +170.44% | +537.45% | +6,045.71% | 12.55B | |
| -1.36% | +15.21% | +8.51% | +15.82% | +28.94% | +443.84% | +143.87% | +28.28% | +1,388.70% | 12.06B | |
| -0.90% | +5.62% | +7.58% | -28.19% | -12.74% | -34.53% | +141.08% | +116.70% | - | 11.69B | |
| -1.44% | +0.70% | -1.76% | +23.61% | +27.07% | +117.16% | +149.20% | +186.31% | +716.38% | 10.96B | |
| -8.81% | -1.09% | -2.50% | -38.13% | -21.90% | -52.35% | +596.94% | +79.03% | +91.05% | 10.9B | |
| +2.14% | +1.90% | +16.20% | +46.59% | +211.75% | +474.09% | +615.45% | -37.05% | -13.08% | 8.98B | |
| +0.10% | -0.16% | +128.15% | +118.45% | +79.87% | +170.18% | +343.96% | +355.30% | - | 8.83B | |
| -4.27% | +3.96% | +27.57% | +25.09% | +14.49% | +24.00% | +316.05% | +317.80% | - | 7.92B | |
| -1.76% | -2.74% | -3.29% | -8.12% | +18.47% | +49.22% | +16.10% | +141.64% | - | 7.89B | |
| -4.05% | -7.55% | -18.48% | -4.57% | +258.59% | +148.25% | +190.98% | -34.56% | - | 7.44B | |
| Average | -1.04% | +1.18% | +11.79% | +17.16% | +44.39% | +93.27% | +223.31% | +210.90% | +1,641.48% | 17.86B | |
| Weighted average by Cap. | -1.11% | +2.05% | +8.18% | +15.86% | +30.30% | +68.67% | +174.11% | +180.73% | +2,679.91% |
- Stock Market
- Stocks
- ACTI Stock
- ACTI Stock
- Sector Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
